BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

527005

SHREEPAC

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SHREE PACETRONIX LTD. Share Price Update

As of the latest trading session, SHREE PACETRONIX LTD. share price is currently at ₹ 70, which is down by ₹ -1.00 from its previous closing. Today, the stock has fluctuated between ₹ 70.00 and ₹ 71.00. Over the past year, SHREE PACETRONIX LTD. has achieved a return of -72.23 %. In the last month alone, the return has been 10.28 %. Read More...

SHREE PACETRONIX LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    25.19

  • P/E Ratio (TTM)

    14.92

  • Beta

    0.38

  • Book Value / share

    37.66

  • Return on equity

    29.27%

  • EPS (TTM)

    4.76

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    -0.11

info icon alternate text

SHREE PACETRONIX LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 3.63
Operating Expense 3.81
Net Profit -0.11
Net Profit Margin (%) -3.03
Earnings Per Share (EPS) -0.32
EBITDA 0.12
Effective Tax Rate (%) 29.41
Particulars SEP 2024 (Values in Cr)
Revenue 4.04
Operating Expense 4.01
Net Profit 0.03
Net Profit Margin (%) 0.74
Earnings Per Share (EPS) 0.08
EBITDA 0.39
Effective Tax Rate (%) 40.00
Particulars JUN 2024 (Values in Cr)
Revenue 4.85
Operating Expense 4.40
Net Profit 0.37
Net Profit Margin (%) 7.62
Earnings Per Share (EPS) 1.03
EBITDA 0.80
Effective Tax Rate (%) 26.00
Particulars MAR 2024 (Values in Cr)
Revenue 6.65
Operating Expense 4.68
Net Profit 1.43
Net Profit Margin (%) 21.50
Earnings Per Share (EPS) 3.96
EBITDA 2.32
Effective Tax Rate (%) 29.35
Particulars DEC 2023 (Values in Cr)
Revenue 4.30
Operating Expense 3.77
Net Profit 0.40
Net Profit Margin (%) 9.30
Earnings Per Share (EPS) 1.11
EBITDA 0.88
Effective Tax Rate (%) 28.57
Particulars MAR 2024 (Values in Cr)
Revenue 22.04
Operating Expense 17.55
Net Profit 3.36
Net Profit Margin (%) 15.24
Earnings Per Share (EPS) 9.33
EBITDA 5.80
Effective Tax Rate (%) 27.27
Particulars MAR 2023 (Values in Cr)
Revenue 20.19
Operating Expense 15.69
Net Profit 3.25
Net Profit Margin (%) 16.09
Earnings Per Share (EPS) 9.02
EBITDA 5.52
Effective Tax Rate (%) 29.34
Particulars MAR 2022 (Values in Cr)
Revenue 9.03
Operating Expense 8.20
Net Profit 0.65
Net Profit Margin (%) 7.19
Earnings Per Share (EPS) 1.81
EBITDA 1.66
Effective Tax Rate (%) 26.13
Particulars MAR 2021 (Values in Cr)
Revenue 7.56
Operating Expense 7.30
Net Profit 0.18
Net Profit Margin (%) 2.38
Earnings Per Share (EPS) 0.51
EBITDA 1.16
Effective Tax Rate (%) 41.93
Particulars MAR 2020 (Values in Cr)
Revenue 8.76
Operating Expense 8.37
Net Profit 0.28
Net Profit Margin (%) 3.19
Earnings Per Share (EPS) 0.77
EBITDA 1.28
Effective Tax Rate (%) 34.14
Particulars MAR 2024 (Values in Cr)
Book Value / Share 36.21
ROE % 29.60
ROCE % 34.65
Total Debt to Total Equity 0.29
EBITDA Margin 27.31
Particulars MAR 2023 (Values in Cr)
Book Value / Share 26.88
ROE % 40.55
ROCE % 46.02
Total Debt to Total Equity 0.33
EBITDA Margin 27.39
Particulars MAR 2022 (Values in Cr)
Book Value / Share 17.82
ROE % 12.96
ROCE % 14.71
Total Debt to Total Equity 0.52
EBITDA Margin 20.04
Particulars MAR 2021 (Values in Cr)
Book Value / Share 15.65
ROE % 0.89
ROCE % 5.40
Total Debt to Total Equity 0.58
EBITDA Margin 13.10
Particulars MAR 2020 (Values in Cr)
Book Value / Share 15.50
ROE % 4.40
ROCE % 8.13
Total Debt to Total Equity 0.66
EBITDA Margin 14.14
Particulars MAR 2024 (Values in Cr)
Book Value / Share 36.55
ROE % 29.27
ROCE % 34.41
Total Debt to Total Equity 0.28
EBITDA Margin 26.72
Particulars MAR 2023 (Values in Cr)
Book Value / Share 27.22
ROE % 39.76
ROCE % 45.67
Total Debt to Total Equity 0.31
EBITDA Margin 27.39
Particulars MAR 2022 (Values in Cr)
Book Value / Share 18.19
ROE % 10.44
ROCE % 12.80
Total Debt to Total Equity 0.45
EBITDA Margin 18.38
Particulars MAR 2021 (Values in Cr)
Book Value / Share 16.38
ROE % 3.10
ROCE % 7.62
Total Debt to Total Equity 0.46
EBITDA Margin 15.34
Particulars MAR 2020 (Values in Cr)
Book Value / Share 15.87
ROE % 5.02
ROCE % 9.29
Total Debt to Total Equity 0.50
EBITDA Margin 14.61
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.80
Total Assets 21.74
Total Liabilities 21.74
Total Equity 13.03
Share Outstanding 3599400
Price to Book Ratio 4.15
Return on Assets (%) 15.44
Return on Capital (%) 19.38
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.84
Total Assets 16.54
Total Liabilities 16.54
Total Equity 9.67
Share Outstanding 3599400
Price to Book Ratio 3.59
Return on Assets (%) 19.70
Return on Capital (%) 27.48
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.43
Total Assets 12.17
Total Liabilities 12.17
Total Equity 6.41
Share Outstanding 3599400
Price to Book Ratio 1.12
Return on Assets (%) 6.41
Return on Capital (%) 8.26
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.77
Total Assets 10.97
Total Liabilities 10.97
Total Equity 5.63
Share Outstanding 3599400
Price to Book Ratio 0.71
Return on Assets (%) 0.48
Return on Capital (%) 0.6
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.52
Total Assets 10.98
Total Liabilities 10.98
Total Equity 5.58
Share Outstanding 3599400
Price to Book Ratio 0.00
Return on Assets (%) 2.15
Return on Capital (%) 2.87
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.71
Total Assets 21.81
Total Liabilities 21.81
Total Equity 13.15
Share Outstanding 3599400
Price to Book Ratio 4.15
Return on Assets (%) 15.39
Return on Capital (%) 19.27
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.83
Total Assets 16.60
Total Liabilities 16.60
Total Equity 9.79
Share Outstanding 3599400
Price to Book Ratio 3.59
Return on Assets (%) 19.55
Return on Capital (%) 27.16
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.57
Total Assets 12.04
Total Liabilities 12.04
Total Equity 6.54
Share Outstanding 3599400
Price to Book Ratio 1.12
Return on Assets (%) 5.41
Return on Capital (%) 6.92
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.69
Total Assets 10.69
Total Liabilities 10.69
Total Equity 5.89
Share Outstanding 3599400
Price to Book Ratio 0.71
Return on Assets (%) 1.71
Return on Capital (%) 2.13
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.43
Total Assets 10.33
Total Liabilities 10.33
Total Equity 5.71
Share Outstanding 3599400
Price to Book Ratio 0.00
Return on Assets (%) 2.66
Return on Capital (%) 3.44
Particulars MAR 2024 (Values in Cr)
Net Income 4.62
Cash from Operations 1.11
Cash from Investing -1.66
Cash from Financing 1.74
Net change in Cash 0.04
Free Cash Flow 2.49
Particulars MAR 2023 (Values in Cr)
Net Income 4.62
Cash from Operations 2.63
Cash from Investing -1.41
Cash from Financing -1.10
Net change in Cash -0.82
Free Cash Flow 3.87
Particulars MAR 2022 (Values in Cr)
Net Income 1.06
Cash from Operations 1.89
Cash from Investing -1.18
Cash from Financing -0.44
Net change in Cash 0.12
Free Cash Flow 2.29
Particulars MAR 2021 (Values in Cr)
Net Income 0.13
Cash from Operations 1.26
Cash from Investing -0.53
Cash from Financing -0.31
Net change in Cash 0.24
Free Cash Flow 2.02
Particulars MAR 2020 (Values in Cr)
Net Income 0.35
Cash from Operations 2.31
Cash from Investing -1.00
Cash from Financing -1.17
Net change in Cash 0.07
Free Cash Flow 3.75
Particulars MAR 2024 (Values in Cr)
Net Income 4.62
Cash from Operations 1.11
Cash from Investing -1.67
Cash from Financing 1.74
Net change in Cash 0.04
Free Cash Flow 2.49
Particulars MAR 2023 (Values in Cr)
Net Income 4.59
Cash from Operations 3.31
Cash from Investing -1.40
Cash from Financing -0.96
Net change in Cash 0.02
Free Cash Flow 4.53
Particulars MAR 2022 (Values in Cr)
Net Income 0.88
Cash from Operations 0.72
Cash from Investing -1.10
Cash from Financing -0.14
Net change in Cash -0.65
Free Cash Flow 1.12
Particulars MAR 2021 (Values in Cr)
Net Income 0.31
Cash from Operations 1.16
Cash from Investing -0.58
Cash from Financing -0.15
Net change in Cash 0.25
Free Cash Flow 1.83
Particulars MAR 2020 (Values in Cr)
Net Income 0.41
Cash from Operations 1.54
Cash from Investing -0.56
Cash from Financing -0.80
Net change in Cash 0.11
Free Cash Flow 2.24
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6992.60 76.74 13.41 100542.86 5690.80 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 78.74 192.05 4.94 147.57 51.01 / 98.70
TRANSGENE BIOTEK LTD. 3.75 0.00 2.62 28.41 3.22 / 10.84
VIMTA LABS LIMITED 1037.40 37.94 6.72 2306.61 420.00 / 1183.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6992.60 83.66 12.27 100542.86 5690.80 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 31.25 0.00 -16.74 23.34 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5584.95 29.60 6.27 6109.94 3750.00 / 6400.00

SHREE PACETRONIX LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
70.00 -1.40 redarrow
red-green-graph indicator
14 Bearish
2 Bullish
  • 5 Days 70.70
  • 26 Days 70.80
  • 10 Days 70.60
  • 50 Days 75.70
  • 12 Days 70.50
  • 100 Days 90.60
  • 20 Days 70.40
  • 200 Days 118.00
70.83 PIVOT

First Support

70.67

First Resistance

71.17

Second Support

70.33

Second Resistance

71.33

Third Support

70.17

Third Resistance

71.67

RSI

50.50

ADX

13.72

MACD

-0.28

Williams % R

-49.26

Commodity Channel Index (CCI)

36.12

Date

2025-04-29

Week

785.00

Same Day

53.00

Month

870.00

1 Year

0.39

3 Year

0.57

Over 1 Month

10.28%

down

Over 1 Year

-72.23%

down

Over 3 Months

-20.22%

down

Over 3 Years

49.38%

down

Over 6 Months

-43.15%

down

Over 5 Years

44.67%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

SHREE PACETRONIX LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
75.75%
Promoter Holdings
24.24%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
14.78%
Name Shares Category
Atul Kumar Sethi 705506.0 (19.6%) Shareholding of Promoter and Promoter Group
Bio-pace Technology Inc 570087.0 (15.84%) Public Shareholding
Astral Tradeplace Llp 179135.0 (4.98%) Public Shareholding
Epcot Lifestyles Private Limited 159327.0 (4.43%) Public Shareholding
Amita Sethi 115074.0 (3.2%) Shareholding of Promoter and Promoter Group
Ajay Kumar Aggarwal 76453.0 (2.12%) Public Shareholding
Dheeraj Kumar Lohia 70436.0 (1.96%) Public Shareholding
Chain Singh Modi 60390.0 (1.68%) Public Shareholding
Mathew Samuel Kalarickal 53781.0 (1.49%) Public Shareholding
Ayush Mittal 50000.0 (1.39%) Public Shareholding
Ashish Sethi 39477.0 (1.1%) Shareholding of Promoter and Promoter Group
Akash Sethi 12699.0 (0.35%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

SHREE PACETRONIX LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
24 Sep 2007 0.5 Final 26 Sep 2007 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

SHREE PACETRONIX LTD. Share Price

Shree Pacetronix Ltd, a leading manufacturer / exporter of Pacemakers, was incorporated in January , 1988 as a Private Limited Company and converted into a Public Limited Company in 1993. It has a operative plant at Pithampur, Madhya Pradesh with installed
capacity to produce 4800 pacemakers per annum.

The Company is one among the Corporates which is operating in global market for Pacemaker. Pacemakers are medical devices that are used to impart electrical pulses to the heart, to ensure normal heart rate. Pacemakers are used to treat patients suffering mainly from heart conditions, such as heart failure and arrhythmias. These devices are implanted under patient's chest by cardiologist to deal with various indications and used for the treatment of heart medical complications/conditions.

Parent organization Indian Private
NSE symbol [-]
Founded 1988
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Shree Pacetronix Ltd?

Answer Field

The share price of Shree Pacetronix Ltd for NSE is ₹ 0.00 and for BSE is ₹ 70.00.

What is the Market Cap of Shree Pacetronix Ltd?

Answer Field

The market cap of Shree Pacetronix Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 25.20 Cr. as of now.

What is the 52 Week High and Low of Shree Pacetronix Ltd?

Answer Field

The 52 Week High and Low of Shree Pacetronix Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 268.50 and ₹ 61.11.

How to Buy Shree Pacetronix Ltd share?

Answer Field

You can trade in Shree Pacetronix Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Shree Pacetronix Ltd?

Answer Field

The 1 year returns on the stock has been -72.23%.

What is the Current Share Price of Shree Pacetronix Ltd?

Answer Field

Shree Pacetronix Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 70.00 as on Apr 30 2025 03:15 PM.

What is the Market Cap of Shree Pacetronix Ltd Share?

Answer Field

The market cap of Shree Pacetronix Ltd for NSE ₹ 0.0 & for BSE ₹ 25.20 as on Apr 30 2025 03:15 PM.

What is the P/E Ratio of Shree Pacetronix Ltd Share?

Answer Field

As on Apr 30 2025 03:15 PM the price-to-earnings (PE) ratio for Shree Pacetronix Ltd share is 14.92.

What is the PB ratio of Shree Pacetronix Ltd Share?

Answer Field

As on Apr 30 2025 03:15 PM, the price-to-book (PB) ratio for Shree Pacetronix Ltd share is 37.66.

How to Buy Shree Pacetronix Ltd Share?

Answer Field

You can trade in Shree Pacetronix Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Shree Pacetronix Ltd Share on Bajaj Broking App?

Answer Field

To buy Shree Pacetronix Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Shree Pacetronix Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|